Keon Woong Moon
Overview
Explore the profile of Keon Woong Moon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim B, Nah D, Choi K, Bae J, Rhee M, Jang J, et al.
Korean Circ J
. 2020 Oct;
50(11):1026-1036.
PMID: 33118336
Background And Objectives: The relationship between the hospital percutaneous coronary intervention (PCI) volumes and the in-hospital clinical outcomes of patients with acute myocardial infarction (AMI) remains the subject of debate....
2.
Shin D, Kang H, Jang J, Moon K, Song Y, Park D, et al.
Korean Circ J
. 2019 Jul;
49(12):1136-1151.
PMID: 31347316
Background And Objectives: In this second report from Korean percutaneous coronary intervention (K-PCI) registry, we sought to describe the updated information of PCI practices and Korean practice pattern of PCI...
3.
Kim J, Choi W, Kim K, Nam C, Hong B, Kim J, et al.
Korean Circ J
. 2019 Jun;
49(11):1022-1032.
PMID: 31190480
Background And Objectives: Intermediate coronary lesion that can be under- or over-estimated by visual estimation frequently results in stenting of functionally nonsignificant lesions or deferral of percutaneous coronary intervention (PCI)...
4.
Kim C, Park K, Kang J, Park B, Cha K, Rhew J, et al.
Circ J
. 2019 Jun;
83(7):1489-1497.
PMID: 31155604
Background: There are limited data on the long-term outcome of platinum chromium-based everolimus-eluting stents (PtCr-EES) vs. cobalt chromium-based zotarolimus-eluting stents (CoCr-ZES). Methods and results: A total of 3,755 patients undergoing...
5.
Choi I, Koh Y, Lim S, Choo E, Kim J, Hwang B, et al.
Am J Cardiol
. 2016 Mar;
117(7):1039-46.
PMID: 26993974
Chronic total occlusion (CTO) in a non-infarct-related artery (IRA) is an independent predictor of clinical outcomes in patients with acute myocardial infarction (AMI). This study evaluated the impact of successful...
6.
Hwang H, Park M, Yoon H, Chang Y, Yang C, Kim S, et al.
Am J Nephrol
. 2014 Nov;
40(4):345-52.
PMID: 25358406
Background/aims: Atrial fibrillation (AF) often coexists with acute myocardial infarction (AMI), and chronic kidney disease (CKD) is a major risk for AMI. However, the combined impact of CKD and AF...
7.
Park K, Kang S, Kang H, Koo B, Park B, Cha K, et al.
J Am Coll Cardiol
. 2014 May;
63(25 Pt A):2805-16.
PMID: 24814486
Objectives: This study sought to test whether the newly developed platinum chromium (PtCr)-based everolimus-eluting stent (EES) is noninferior to the cobalt chromium (CoCr)-based zotarolimus-eluting stent (ZES) in all-comers receiving percutaneous...
8.
Choi I, Koh Y, Lim S, Kim J, Chang M, Kang M, et al.
Am J Cardiol
. 2013 Dec;
113(3):457-64.
PMID: 24332246
Stent length has been considered an important predictor of adverse events after percutaneous coronary intervention, even with the first-generation drug-eluting stents (DESs). The introduction of newer-generation DES has further reduced...
9.
Park K, Kang S, Park J, Yang H, Kang H, Koo B, et al.
JACC Cardiovasc Interv
. 2013 Sep;
6(9):932-42.
PMID: 24050860
Objectives: This study sought to test the noninferiority of triple antiplatelet therapy (TAT) versus double-dose clopidogrel dual antiplatelet therapy (DDAT) in patients undergoing percutaneous coronary intervention (PCI). Background: Antiplatelet regimen...
10.
Park K, Park B, Kang S, Park J, Lee S, Cha K, et al.
Trials
. 2012 Apr;
13:29.
PMID: 22463698
Background: Second-generation drug-eluting stents (DES) have raised the bar of clinical performance. These stents are mostly made from cobalt chromium alloy. A newer generation DES has been developed from platinum...